2-(1H-Imidazol-1-yl)benzonitrile

Catalog No. :
ACDTVB718
CAS No. :
25373-49-3
Molecular Formula :
C10H7N3
Molecular Weight :
169.19

IUPAC Name:2-(1H-imidazol-1-yl)benzonitrile

2-(1H-Imidazol-1-yl)benzonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$69.00Login to see priceInquiryInquiry
5g98%$146.00Login to see priceInquiryInquiry
10g98%$233.00Login to see priceInquiryInquiry
25g98%$445.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(1H-Imidazol-1-yl)benzonitrile
IUPAC Name2-(1H-imidazol-1-yl)benzonitrile
MDL No.H183177
Molecular FormulaC10H7N3
Molecular Weight169.19
SMILESN#CC1=CC=CC=C1N2C=CN=C2
InChI KeyMNKBJOSIVSQUBI-UHFFFAOYSA-N
Synonym2-(1H-imidazol-1-yl)benzonitrile | 25373-49-3 | 2-imidazol-1-ylbenzonitrile | 2-(1H-imidazol-1-yl)benzenecarbonitrile | 2-(1-imidazolyl)benzonitrile | 1-(2-Cyanophenyl)imidazole | Benzonitrile, o-imidazol-1-yl- | 1-(2-cyanophenyl)-imidazole | 2-Imidazol-1-yl-benzonitrile
CAS No.25373-49-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACDTVB718 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDLYM406 route compound structure diagram
    ACDLYM4065587-42-8 In Stock
  4. Then
  5. ACDTVB718 route product structure diagram
    ACDTVB71825373-49-3
Inquiry

2. ACDTVB718 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCLWE921 route compound structure diagram
    ACCLWE9214387-36-4 In Stock
  2. Plus
  3. ACDLYM406 route compound structure diagram
    ACDLYM4065587-42-8 In Stock
  4. Then
  5. ACDTVB718 route product structure diagram
    ACDTVB71825373-49-3
Inquiry

Comments (0)